Glioma is a metabolically affected disease due to IDH mutation (Dang et al., 2009), and LGG shows the broadest survival correlation with metabolic disorders compared to other tumors (Vander Heiden and DeBerardinis, 2017). Here, IDH1 is linked to central nervous system cancer.